Open AccessPulmonary aspergillosis associated to COVID-19
Author(s) -
Aurelia Cebotaru,
Oxana Munteanu,
Eugenia Scutaru,
Victor Botnaru
Publication year - 2021
Publication title -
buletinul academiei de ştiinţe a moldovei: ştiinţe medicale
Language(s) - English
Resource type - Journals
ISSN - 1857-0011
DOI - 10.52692/1857-0011.2021.1-69.34
Subject(s) - pulmonary aspergillosis , aspergillosis , covid-19 , pandemic , incidence (geometry) , aspergillus , medicine , coronavirus , intensive care medicine , pathology , immunology , biology , microbiology and biotechnology , disease , infectious disease (medical specialty) , outbreak , physics , optics
Infection with novel coronavirus (SARS-CoV-2) remains one of the most important pandemics till present, becoming an equation with several unknowns, one of them being the associated fungal infections. Pulmonary mycoses have an increased incidence and mortality, the most common germ identified among cases of COVID-19 is Aspergillus spp. Due to discrepancies in defining and diagnostic criteria, but also nonspecific clinical-imaging manifestations, COVID-19-associated pulmonary aspergillosis remains a diagnostic and management challenge.